Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWO
2201
Two Harbors Investment
TWO
$1.27B
| $2.59M | ﹤0.01% |
112,345
+48,620
| +76% | +$1.21M |
|
2202
Bruker
BRKR
$9.57B
| $2.59M | ﹤0.01% |
30,884
-63,676
| -67% | -$5.1M |
|
|
AVNS
2203
DELISTED
Avanos Medical
AVNS
| $2.59M | ﹤0.01% |
74,692
+19,563
| +35% | +$632K |
|
2204
Ironwood Pharmaceuticals
IRWD
$696M
| $2.59M | ﹤0.01% |
222,204
+6,488
| +3% | +$79.6K |
|
2205
Fortis
FTS
$29B
| $2.58M | ﹤0.01% |
53,534
-176,101
| -77% | -$7.97M |
|
2206
Cohu
COHU
$2.26B
| $2.58M | ﹤0.01% |
67,761
+22,665
| +50% | +$777K |
|
2207
B&G Foods
BGS
$287M
| $2.57M | ﹤0.01% |
83,790
-34,536
| -29% | -$1.06M |
|
2208
McGrath RentCorp
MGRC
$2.81B
| $2.57M | ﹤0.01% |
32,076
+15,737
| +96% | +$1.21M |
|
2209
Wendy's
WEN
$1.4B
| $2.57M | ﹤0.01% |
107,819
-102,051
| -49% | -$2.27M |
|
|
AGNT
2210
AGNT Inc
AGNT
$666M
| $2.57M | ﹤0.01% |
76,198
+23,687
| +45% | +$977K |
|
2211
The Greenbrier Companies
GBX
$1.52B
| $2.56M | ﹤0.01% |
55,885
+6,908
| +14% | +$300K |
|
|
DQ
2212
Daqo New Energy
DQ
$823M
| $2.56M | ﹤0.01% |
63,486
-233,040
| -79% | -$13.5M |
|
2213
AptarGroup
ATR
$8.55B
| $2.56M | ﹤0.01% |
20,900
-58,896
| -74% | -$7.33M |
|
|
VRAY
2214
DELISTED
ViewRay, Inc.
VRAY
| $2.54M | ﹤0.01% |
460,953
+404,388
| +715% | +$2.46M |
|
2215
Addus HomeCare
ADUS
$2.16B
| $2.54M | ﹤0.01% |
27,126
-738
| -3% | -$66.4K |
|
2216
Green Dot
GDOT
$743M
| $2.54M | ﹤0.01% |
69,953
+26,693
| +62% | +$1.09M |
|
2217
PUT
Halliburton
HAL
$26.9B
| $2.53M | ﹤0.01% |
110,700
| – | – |
|
2218
Revolve Group
RVLV
$1.8B
| $2.53M | ﹤0.01% |
45,108
+27,726
| +160% | +$1.95M |
|
2219
Sally Beauty Holdings
SBH
$1.43B
| $2.53M | ﹤0.01% |
136,835
-2,728
| -2% | -$49.7K |
|
2220
AAR Corp
AIR
$5.59B
| $2.52M | ﹤0.01% |
64,598
+27,667
| +75% | +$988K |
|
2221
CALL
RH
RH
$3.13B
| $2.52M | ﹤0.01% |
4,700
| – | – |
|
2222
PUT
Becton Dickinson
BDX
$45.6B
| $2.52M | ﹤0.01% |
+10,250
| New | +$2.46M |
|
2223
Editas Medicine
EDIT
$396M
| $2.51M | ﹤0.01% |
94,494
+3,755
| +4% | +$129K |
|
2224
CALL
Energy Transfer Partners
ET
$70.1B
| $2.51M | ﹤0.01% |
304,500
+200,000
| +191% | +$1.82M |
|
2225
Andersons Inc
ANDE
$2.41B
| $2.5M | ﹤0.01% |
64,658
-20,380
| -24% | -$715K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.